Bio Essence Statistics
Total Valuation
Bio Essence has a market cap or net worth of 14.74 million. The enterprise value is 16.27 million.
| Market Cap | 14.74M |
| Enterprise Value | 16.27M |
Important Dates
The next estimated earnings date is Wednesday, May 27, 2026.
| Earnings Date | May 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Bio Essence has 53.81 million shares outstanding. The number of shares has increased by 4.57% in one year.
| Current Share Class | 53.81M |
| Shares Outstanding | 53.81M |
| Shares Change (YoY) | +4.57% |
| Shares Change (QoQ) | +18.26% |
| Owned by Insiders (%) | 63.92% |
| Owned by Institutions (%) | n/a |
| Float | 19.41M |
Valuation Ratios
The trailing PE ratio is 8.33.
| PE Ratio | 8.33 |
| Forward PE | n/a |
| PS Ratio | 6.20 |
| PB Ratio | -10.33 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 12.45 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 12.45 |
| EV / Sales | 6.85 |
| EV / EBITDA | 12.02 |
| EV / EBIT | 12.32 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.37
| Current Ratio | 0.37 |
| Quick Ratio | 0.02 |
| Debt / Equity | n/a |
| Debt / EBITDA | 1.16 |
| Debt / FCF | n/a |
| Interest Coverage | 604.53 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 142.99% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -96.29% |
| Weighted Average Cost of Capital (WACC) | 64.24% |
| Revenue Per Employee | 593,979 |
| Profits Per Employee | 326,831 |
| Employee Count | 4 |
| Asset Turnover | 4.12 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Bio Essence has paid 10,639 in taxes.
| Income Tax | 10,639 |
| Effective Tax Rate | 0.81% |
Stock Price Statistics
The stock price has increased by +41.51% in the last 52 weeks. The beta is 12.14, so Bio Essence's price volatility has been higher than the market average.
| Beta (5Y) | 12.14 |
| 52-Week Price Change | +41.51% |
| 50-Day Moving Average | 0.17 |
| 200-Day Moving Average | 0.66 |
| Relative Strength Index (RSI) | 49.06 |
| Average Volume (20 Days) | 12,454 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.37 |
Income Statement
In the last 12 months, Bio Essence had revenue of 2.38 million and earned 1.31 million in profits. Earnings per share was 0.03.
| Revenue | 2.38M |
| Gross Profit | 1.73M |
| Operating Income | 1.32M |
| Pretax Income | 1.32M |
| Net Income | 1.31M |
| EBITDA | 1.32M |
| EBIT | 1.32M |
| Earnings Per Share (EPS) | 0.03 |
Balance Sheet
The company has 36,177 in cash and 1.57 million in debt, with a net cash position of -1.53 million or -0.03 per share.
| Cash & Cash Equivalents | 36,177 |
| Total Debt | 1.57M |
| Net Cash | -1.53M |
| Net Cash Per Share | -0.03 |
| Equity (Book Value) | -1.43M |
| Book Value Per Share | -0.03 |
| Working Capital | -1.37M |
Cash Flow
| Operating Cash Flow | 1.18M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 235 |
| Net Borrowing | -1.59M |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 72.70%, with operating and profit margins of 55.60% and 55.02%.
| Gross Margin | 72.70% |
| Operating Margin | 55.60% |
| Pretax Margin | 55.47% |
| Profit Margin | 55.02% |
| EBITDA Margin | 55.61% |
| EBIT Margin | 55.60% |
| FCF Margin | n/a |
Dividends & Yields
Bio Essence does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.57% |
| Shareholder Yield | -4.57% |
| Earnings Yield | 8.87% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Bio Essence has an Altman Z-Score of -8.89 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -8.89 |
| Piotroski F-Score | 6 |